Nurix Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
30 November
Nurix Therapeutics, Inc. has filed 528 SEC EDGAR filings since 15 May 2012

SEC filing history

Showing 476-500 of 528 matching filings.

Per page
25
Current page
20
SC 13G/A File 005-91591

SEC SCHEDULE 13G

Filing date
04 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39398

8-K

Filing date
07 Dec 2020
Reporting date
07 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Dec 2020
Reporting date
30 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39398

8-K

Filing date
26 Oct 2020
Reporting date
23 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Oct 2020
Reporting date
21 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39398

8-K

Filing date
14 Oct 2020
Reporting date
14 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39398

8-K

Filing date
14 Oct 2020
Reporting date
14 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91591

SEC SCHEDULE 13G

Filing date
10 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91591

SC 13G

Filing date
03 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-239651

424B4

Filing date
24 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-240065

S-8

Filing date
24 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-239651

EFFECT filing

Filing date
23 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
23 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
23 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
23 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
23 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
23 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
23 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .